Related references
Note: Only part of the references are listed.The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2023)
The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis
Bei He et al.
FRONTIERS IN IMMUNOLOGY (2022)
The IL-1 cytokine family as custodians of barrier immunity
Laura Matarazzo et al.
CYTOKINE (2022)
Fungal microbiome in inflammatory bowel disease: a critical assessment
David M. Underhill et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis
Sangmin Lee et al.
JOURNAL OF CROHNS & COLITIS (2021)
Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-κB activation
Rana Al-Sadi et al.
PLOS ONE (2021)
Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases
Ekaterina O. Gubernatorova et al.
FRONTIERS IN IMMUNOLOGY (2021)
Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease
Jonathan Wei Jie Lee et al.
CELL HOST & MICROBE (2021)
Various Forms of Tuberculosis in Patients with Inflammatory Bowel Diseases Treated with Biological Agents
Adam Krusinski et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2021)
Emerging treatments for inflammatory bowel disease
Karl Hazel et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease
Stepan Coufal et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease
Federico Perez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Raja Atreya et al.
FRONTIERS IN MEDICINE (2020)
Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development
Siddhartha S. Ghosh et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
Dual roles of IL-18 in colitis through regulation of the function and quantity of goblet cells
Zhichen Pu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Tumour Necrosis Factor Alpha in Intestinal Homeostasis and Gut Related Diseases
Barbara Ruder et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis
Radislav Nakov et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2019)
IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions
Michelle A. Williams et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response
Stepan Coufal et al.
CELLS (2019)
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naive and Non-naive Patients With Crohn's Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease
Fabio Salvatore Macaluso et al.
JOURNAL OF CROHNS & COLITIS (2019)
The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis
Alena Kokesova et al.
PLOS ONE (2019)
Interleukin-33 Promotes REG3γ Expression in Intestinal Epithelial Cells and Regulates Gut Microbiota
Yi Xiao et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy
S. Bank et al.
PHARMACOGENOMICS JOURNAL (2018)
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases
Federico Carbone et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Can We Predict the Efficacy of Anti-TNF-alpha Agents?
Loris Riccardo Lopetuso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota
Sozaburo Ihara et al.
JOURNAL OF GASTROENTEROLOGY (2017)
Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia
Alina Aguirre et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Matrix metalloproteinases as regulators of inflammatory processes
Barbara Fingleton
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway
Rana Al-Sadi et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis
Ankit Malik et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease
Casper Steenholdt et al.
MEDICINE (2016)
Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease
Stepan Coufal et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease - a SONIC post hoc analysis
J. -F. Colombel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Roni Nowarski et al.
CELL (2015)
Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort
Pascal Juillerat et al.
INFLAMMATORY BOWEL DISEASES (2015)
Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naive to anti-TNF therapy: An indirect treatment comparison meta-analysis
Kristian Thorlund et al.
JOURNAL OF CROHNS & COLITIS (2014)
Polymorphisms in the Inflammatory Pathway Genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG Are Associated with Susceptibility of Inflammatory Bowel Disease in a Danish Cohort
Steffen Bank et al.
PLOS ONE (2014)
Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease
S. Bank et al.
PHARMACOGENOMICS JOURNAL (2014)
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Mamdouh A. K. Sedhom et al.
GUT (2013)
Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
Jason W. Harper et al.
INFLAMMATORY BOWEL DISEASES (2013)
Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease
Marta Kovacs et al.
JOURNAL OF CROHNS & COLITIS (2013)
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study
Kang-Moon Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases
Gabor Lakatos et al.
DIGESTIVE DISEASES (2012)
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: A large single centre experience
Michael B. Sprakes et al.
JOURNAL OF CROHNS & COLITIS (2012)
LPS-binding Protein Enables Intestinal Epithelial Restitution Despite LPS Exposure
Juli M. Richter et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2012)
The Behavior of Matrix Metalloproteinase-9 in Lymphocytic Colitis, Collagenous Colitis and Ulcerative Colitis
Gabor Lakatos et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Alexander C. Ford et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease
Leokadia Bak-Romaniszyn et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti-Tumor Necrosis Factor Therapy
Jean-Francois Rahier et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens
Stefan Mueller et al.
GUT (2010)
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
Ayako Kobori et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
Luca Pastorelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis
I. Arijs et al.
GUT (2009)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease
Michael A. Manfredi et al.
INFLAMMATORY BOWEL DISEASES (2008)
Cutting edge:: Priming of NK cells by IL-18
Julie Chaix et al.
JOURNAL OF IMMUNOLOGY (2008)
FactoMineR: An R package for multivariate analysis
Sebastien Le et al.
JOURNAL OF STATISTICAL SOFTWARE (2008)
ROCR: visualizing classifier performance in R
T Sing et al.
BIOINFORMATICS (2005)
PK1/EG-VEGF induces monocyte differentiation and activation
M Dorsch et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Predictors of response to infliximab in luminal Crohn's disease
D Laharie et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2005)
The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease
M Eivindson et al.
HORMONE RESEARCH (2005)
Increased expression of receptor activator of NF-κB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients
N Franchimont et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
TGF-β1 production in inflammatory bowel disease:: differing production patterns in Crohn's disease and ulcerative colitis
B Del Zotto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Diagnosis of multiple cancer types by shrunken centroids of gene expression
R Tibshirani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells
T Gutsmann et al.
INFECTION AND IMMUNITY (2001)
Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease
A Rector et al.
GENES AND IMMUNITY (2001)
CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro:: Lipopolysaccharide activation of epithelial cells revisited
DP Funda et al.
INFECTION AND IMMUNITY (2001)
Serum transforming growth factor-β1 levels increase in response to successful anti-inflammatory therapy in ulcerative colitis
A Sambuelli et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Distinct pathways of cell migration and antiapoptotic response to epithelial injury: Structure-function analysis of human intestinal trefoil factor
K Kinoshita et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
